Business News
DOJ Investigates McKinsey For Role In Opioid Sales Strategy
The US Justice Department is investigating McKinsey & Company for its consulting work with opioid manufacturers, including strategies to boost sales during the opioid crisis.
The probe was spearheaded by the US attorneys' offices in Massachusetts, the Western District of Virginia, and the department's civil division in Washington.
The inquiry follows the company’s agreement to pay $1 billion to settle several US lawsuits over its opioid consultancy, primarily with Purdue Pharma, the maker of OxyContin.
Despite the settlements, McKinsey has not admitted to any wrongdoing.
Purdue was advised by McKinsey to "turbocharge" sales of its opioids, even as the crisis claimed hundreds of thousands of American lives.
The Wall Street Journal first reported the ongoing criminal investigation, which has been active for a few years.
Pharmaceutical company Endo, which also engaged McKinsey for opioid sales strategies, revealed it received a subpoena related to this investigation in December 2020.
Another company, Mallinckrodt, reported a similar subpoena from the exact US attorney's office last year, hinting at the broad scope of the federal probe.
... Read More